Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.50
Bid: 30.00
Ask: 31.00
Change: -2.00 (-6.15%)
Spread: 1.00 (3.333%)
Open: 32.50
High: 32.50
Low: 30.50
Prev. Close: 32.50
ESYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting and Open Offer

26 Jul 2021 10:57

RNS Number : 4476G
essensys PLC
26 July 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) ("UK MAR").

 

26 July 2021

essensys plc

 

Results of General Meeting and Open Offer

Issue of Equity and

Total voting rights

 

essensys plc (AIM: ESYS) ("essensys", the "Company" or, together with its subsidiary undertakings, the "Group"), the leading global provider of mission critical software-as-a-service ("SaaS") platforms and on-demand cloud services to the flexible workspace industry, is pleased to announce all resolutions put to shareholders at the General Meeting held earlier today in connection with the Fundraising, were duly passed.

Furthermore, the Company is pleased to announce that it has raised approximately £1.87 million under the Open Offer (before expenses) following the receipt of valid applications for 657,338 Open Offer Shares from Qualifying Shareholders, including applications under the Excess Application Facility. This represents 93.7 per cent. of the available Open Offer Shares. Accordingly, Qualifying Shareholders who have validly applied for Open Offer Shares will, subject to the conditions below, receive their full Open Offer Entitlement.

The Company has therefore raised approximately £33.2 million (before expenses) through the Fundraising and has issued and allotted 10,984,552 Primary Placing Shares and 657,338 Open Offer Shares. Application has been made to the London Stock Exchange for 11,641,890 New Ordinary Shares to be admitted to trading on AIM. Admission is expected at 8.00 a.m. on 27 July 2021.

The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares.

The Fundraising remains conditional, inter alia, upon Admission and neither the Placing Agreement nor the Sell-down Agreement being terminated in accordance with their terms.

 

Total Voting Rights

Following Admission, the Company will have 64,385,219 Ordinary Shares in issue. No shares are held in treasury, therefore, the total number of voting rights in the Company following Admission will be 64,385,219.

Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, capitalised terms used in this announcement shall have the same meanings as defined in the Circular, published by the Company on 9 July 2021.

 

For further information, please contact:

 

essensys plc

+44 (0)20 3102 5252

Mark Furness (Chief Executive Officer)Alan Pepper (Chief Financial Officer)

 

Singer Capital Markets (nominated adviser, joint broker and joint bookrunner)

+44 (0)20 7496 3000

Peter Steel / Harry Gooden / George Tzimas

 

Berenberg (joint broker and joint bookrunner)

+44 (0)20 3207 7800

Ben Wright / Mark Whitmore / Tejas Padalkar

 

FTI Consulting (public relations adviser)

+44 (0)20 3727 1000

Jamie Ricketts / Eve Kirmatzis / Talia Jessener / Victoria Caton

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFIFEADEIRFIL
Date   Source Headline
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding
8th Nov 20215:54 pmRNSPosting of Annual Report and Accounts & AGM Notice
25th Oct 20215:04 pmRNSHolding(s) in Company
19th Oct 20217:00 amRNSFull Year Results
15th Oct 20217:00 amRNSNotice of Investor Meet Company Presentation
14th Oct 20217:00 amRNSCustomer Renewal
12th Oct 20219:00 amRNSNotice of Results
24th Aug 20217:00 amRNSPre-Close Trading Update
3rd Aug 20217:00 amRNSAppointment of CEO Asia Pacific
29th Jul 20211:35 pmRNSHolding(s) in Company
28th Jul 20216:15 pmRNSHolding(s) in Company
28th Jul 20216:13 pmRNSHolding(s) in Company
28th Jul 20216:12 pmRNSHolding(s) in Company
27th Jul 20218:50 amRNSDirector/PDMR Shareholding
26th Jul 202110:57 amRNSResults of General Meeting and Open Offer
9th Jul 20214:44 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
9th Jul 20217:00 amRNSResult of Placing
8th Jul 20214:35 pmRNSProposed Fundraising
4th May 202111:44 amRNSHolding(s) in Company
21st Apr 202110:07 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSDirector/PDMR Dealing
23rd Mar 20217:00 amRNSHalf-year Report
16th Mar 20212:00 pmRNSFlex Services Platform launch
10th Mar 202112:37 pmRNSNotice of Investor Meet Company Presentation
10th Mar 20217:00 amRNSNotice of Results
18th Feb 20217:00 amRNSessensys Trading Update - 18.02.2021
16th Feb 20218:28 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSAppointment of Joint Corporate Broker
24th Dec 20209:46 amRNSDirector/PDMR Shareholding
24th Nov 20205:29 pmRNSResult of AGM
4th Nov 20207:00 amRNSAppointment of CEO North America and PDMR Dealing
30th Oct 20205:27 pmRNSPosting of Annual Report and Accounts & AGM Notice
13th Oct 20203:35 pmRNSNotice of Investor Meet Company Presentation
13th Oct 20207:00 amRNSessensys plc - Full Year Results
7th Oct 20207:00 amRNSNotice of Results
24th Aug 20203:09 pmRNSHolding(s) in Company
24th Aug 202011:41 amRNSReplacement: Holding(s) in Company
24th Aug 202010:44 amRNSHolding(s) in Company
18th Aug 20207:00 amRNSTrading Statement
9th Apr 202012:17 pmRNSResult of Placing
9th Apr 20207:01 amRNSProposed placing to raise approximately £7 million
9th Apr 20207:00 amRNSHalf year results
24th Mar 20207:01 amRNSessensys - Market and trading update
18th Feb 20207:00 amRNSTrading Statement
30th Jan 20202:26 pmRNSBoard Appointments and Grant of Options
28th Nov 20191:31 pmRNSResult of Annual General Meeting
1st Nov 20194:30 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.